Terms: = Brain cancer AND SUZ12, CHET9, 23512, ENSG00000178691, Q15022, KIAA0160, JJAZ1
15 results:
1. LncRNA CRNDE facilitates epigenetic suppression of CELF2 and LATS2 to promote proliferation, migration and chemoresistance in hepatocellular carcinoma.
Xie SC; Zhang JQ; Jiang XL; Hua YY; Xie SW; Qin YA; Yang YJ
Cell Death Dis; 2020 Aug; 11(8):676. PubMed ID: 32826865
[TBL] [Abstract] [Full Text] [Related]
2. Polycomb-like 2 regulates PRC2 components to affect proliferation in glioma cells.
Wang F; Gao Y; Lv Y; Wu Y; Guo Y; Du F; Wang S; Yu J; Cao X; Li PA
J Neurooncol; 2020 Jun; 148(2):259-271. PubMed ID: 32436117
[TBL] [Abstract] [Full Text] [Related]
3. A novel MBTD1-PHF1 gene fusion in endometrial stromal sarcoma: A case report and literature review.
Han L; Liu YJ; Ricciotti RW; Mantilla JG
Genes Chromosomes Cancer; 2020 Jul; 59(7):428-432. PubMed ID: 32237188
[TBL] [Abstract] [Full Text] [Related]
4. Rare suz12 variants commonly cause an overgrowth phenotype.
Cyrus SS; Cohen ASA; Agbahovbe R; Avela K; Yeung KS; Chung BHY; Luk HM; Tkachenko N; Choufani S; Weksberg R; Lopez-Rangel E; ; Brown K; Saenz MS; Svihovec S; McCandless SE; Bird LM; Garcia AG; Gambello MJ; McWalter K; Schnur RE; An J; Jones SJM; Bhalla SK; Pinz H; Braddock SR; Gibson WT
Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):532-547. PubMed ID: 31736240
[TBL] [Abstract] [Full Text] [Related]
5. miR‑767‑5p inhibits glioma proliferation and metastasis by targeting suz12.
Zhang J; Xu S; Xu J; Li Y; Zhang J; Zhang J; Lu X
Oncol Rep; 2019 Jul; 42(1):55-66. PubMed ID: 31115583
[TBL] [Abstract] [Full Text] [Related]
6. Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas.
Pajtler KW; Wen J; Sill M; Lin T; Orisme W; Tang B; Hübner JM; Ramaswamy V; Jia S; Dalton JD; Haupfear K; Rogers HA; Punchihewa C; Lee R; Easton J; Wu G; Ritzmann TA; Chapman R; Chavez L; Boop FA; Klimo P; Sabin ND; Ogg R; Mack SC; Freibaum BD; Kim HJ; Witt H; Jones DTW; Vo B; Gajjar A; Pounds S; Onar-Thomas A; Roussel MF; Zhang J; Taylor JP; Merchant TE; Grundy R; Tatevossian RG; Taylor MD; Pfister SM; Korshunov A; Kool M; Ellison DW
Acta Neuropathol; 2018 Aug; 136(2):211-226. PubMed ID: 29909548
[TBL] [Abstract] [Full Text] [Related]
7. CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2.
Chen L; Alexe G; Dharia NV; Ross L; Iniguez AB; Conway AS; Wang EJ; Veschi V; Lam N; Qi J; Gustafson WC; Nasholm N; Vazquez F; Weir BA; Cowley GS; Ali LD; Pantel S; Jiang G; Harrington WF; Lee Y; Goodale A; Lubonja R; Krill-Burger JM; Meyers RM; Tsherniak A; Root DE; Bradner JE; Golub TR; Roberts CW; Hahn WC; Weiss WA; Thiele CJ; Stegmaier K
J Clin Invest; 2018 Jan; 128(1):446-462. PubMed ID: 29202477
[TBL] [Abstract] [Full Text] [Related]
8. brain-derived neurotrophic factor involved epigenetic repression of UGT2B7 in colorectal carcinoma: A mechanism to alter morphine glucuronidation in tumor.
Yang ZZ; Li L; Xu MC; Ju HX; Hao M; Gu JK; Jim Wang ZJ; Jiang HD; Yu LS; Zeng S
Oncotarget; 2017 Apr; 8(17):29138-29150. PubMed ID: 28418861
[TBL] [Abstract] [Full Text] [Related]
9. WHO 2016 classification: changes and advancements in the diagnosis of miscellaneous primary CNS tumours.
Sahm F; Reuss DE; Giannini C
Neuropathol Appl Neurobiol; 2018 Feb; 44(2):163-171. PubMed ID: 28295484
[TBL] [Abstract] [Full Text] [Related]
10. No Significant Cytotoxic Effect of the EZH2 Inhibitor Tazemetostat (EPZ-6438) on Pediatric Glioma Cells with Wildtype Histone 3 or Mutated Histone 3.3.
Wiese M; Schill F; Sturm D; Pfister S; Hulleman E; Johnsen SA; Kramm CM
Klin Padiatr; 2016 Apr; 228(3):113-7. PubMed ID: 27135271
[TBL] [Abstract] [Full Text] [Related]
11. Identification of a novel, recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcoma.
Dewaele B; Przybyl J; Quattrone A; Finalet Ferreiro J; Vanspauwen V; Geerdens E; Gianfelici V; Kalender Z; Wozniak A; Moerman P; Sciot R; Croce S; Amant F; Vandenberghe P; Cools J; Debiec-Rychter M
Int J Cancer; 2014 Mar; 134(5):1112-22. PubMed ID: 23959973
[TBL] [Abstract] [Full Text] [Related]
12. MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells.
Peruzzi P; Bronisz A; Nowicki MO; Wang Y; Ogawa D; Price R; Nakano I; Kwon CH; Hayes J; Lawler SE; Ostrowski MC; Chiocca EA; Godlewski J
Neuro Oncol; 2013 Sep; 15(9):1212-24. PubMed ID: 23733246
[TBL] [Abstract] [Full Text] [Related]
13. Differential expression and methylation of brain developmental genes define location-specific subsets of pilocytic astrocytoma.
Lambert SR; Witt H; Hovestadt V; Zucknick M; Kool M; Pearson DM; Korshunov A; Ryzhova M; Ichimura K; Jabado N; Fontebasso AM; Lichter P; Pfister SM; Collins VP; Jones DT
Acta Neuropathol; 2013 Aug; 126(2):291-301. PubMed ID: 23660940
[TBL] [Abstract] [Full Text] [Related]
14. Clinical significance of Polycomb gene expression in brain tumors.
Crea F; Hurt EM; Farrar WL
Mol Cancer; 2010 Sep; 9():265. PubMed ID: 20920292
[TBL] [Abstract] [Full Text] [Related]
15. DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function.
Jin B; Tao Q; Peng J; Soo HM; Wu W; Ying J; Fields CR; Delmas AL; Liu X; Qiu J; Robertson KD
Hum Mol Genet; 2008 Mar; 17(5):690-709. PubMed ID: 18029387
[TBL] [Abstract] [Full Text] [Related]
